This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new Stanford study revealed that among Medicaid patients who had never taken an opioid, 30% developed an opioid dependency following their first prescription. The research showed that opioids that have historically marketed as “safe,” such as tramadol, actually carry quite a high addiction risk for vulnerable populations.
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.
QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective. One of the most underused tactics is your product website.
SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Many organizations have postponed market research due to the pandemic but knowledgeable DTC marketers should be aware of the progressive trends in healthcare.
Communication and transparency are vital to building trust, which necessitates a shift away from traditional DTC marketing. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. Some believe that these behaviors won’t translate to prescription drugs, but that would be a mistake.
The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News. The American Medical Association released a new report on Monday on pharmacy benefit managers. It explained that there is low competition among PBMs and high vertical integration with payers.
The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. billion in 2021.
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes.
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?
Pharmaceutical marketers face a unique challenge. For an in-depth look at how pharma companies succeed in digital advertising, visit Pharma Marketing Network. Many terms, particularly those related to prescription drugs, require fair balance, risk disclosures, and approved messaging. A mix of branded (e.g.,
The post <strong><strong>DTC</strong> Study:</strong> Marketers misaligned with online health seeker needs. So far, our findings seem to concur that TV is the best channel to create awareness about new treatments for chronic conditions. appeared first on World of DTC Marketing.com.
The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
During an interview at the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum held Tuesday in Washington, D.C., This includes the end of the public health emergency, health equity and prescription drug costs. CMS Administrator Chiquita Brooks-LaSure discussed CMS’ key focus areas for 2023.
SUMMARY: There is a huge issue that’s challenging DTC marketers: online health misinformation. While we’re still trying to research the changes it has led to for DTC marketers, there are some observable behaviors taking place that we have examined through Google analytics. 3hree: Beware of changing market parameters.
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. And what are the tools and best practices that make it successful?
More specifically, the data revealed 75 percent of physicians do not trust the information provided to them by those marketers. One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. Despite the number of DTC conferences, there isn’t any one magic formula for successful DTC marketing.
Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever.
The messages that DTC marketers develop and usually tested, again and again, aren’t as effective as we thought they were. Second, I see that in most markets and health conditions, micro-segments have different needs from online health sites, including pharma product sites. Get back to the basics.
Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.
DTC marketing needs to evolve if it’s to remain relevant as part of the brand objectives. DTC marketing today drives patients online to seek more information, and too often, the information they are reading is inaccurate. Targeted in the right publications, print ads can be a great DTC marketing tool.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Think of digital marketing as the GPS guiding your brand through a crowded, competitive landscape.
SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. To master digital marketing, pharma needs to be prepared to fail. It’s a mindset.
In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. Pharma digital marketing strategies must meet users where they areonline.
But how do you stand out in a crowded market? Let’s explore the top strategies pharma marketers can adopt to thrive. Understanding the Pharma Market Landscape To succeed, you need to understand the shifting dynamics of healthcare marketing. They are key decision-makers influencing prescription trends.
Between digital saturation, regulatory scrutiny, and shifting engagement preferences, marketers must be both strategic and adaptable. Understanding how to effectively engage HCPs in pharma marketing is essential for driving brand awareness, product education, and ultimately, prescription behavior.
Health spending for the calendar year may end up lower than it was in 2019 but spending on prescription drugs has not fallen which could be due to price increases. ” While the sample is too small to make any immediate judgments it should be worrying to DTC marketers. This is especially true for undiagnosed patients.
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. How do pharma marketing executives ensure they are using the best tools and strategies? However, with so much information available, finding the right resources can feel overwhelming.
You need to invest in digital marketing too. DTC marketers should be joined at the hip with their market research people. What I have found is that too many DTC marketers make mistakes by applying generic research to their product categories. Marketing is not science; it’s an art.
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. So, how can pharma marketing teams maximize the impact of their Google Ads while staying compliant? To run successful pharma PPC campaigns , marketing teams need a strategic, regulation-compliant approach.
Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? Is TV the best channel?
For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. As digital marketing becomes more automated and data-driven, pharma marketers must embrace new technologies while navigating strict regulations. But what exactly is programmatic advertising?
But how can marketing teams effectively integrate AI into their strategies? By leveraging machine learning, predictive analytics, and natural language processing (NLP) , pharma companies can gain deeper insights into customer behaviors and market trends. For insights on digital transformation in pharma, visit Pharma Marketing Network.
share of the advertising market as a whole. However, recent trends indicate that healthcare marketers are shifting more dollars to digital ads. Today virtually nobody will ask their doctor for/about a new prescription drug product without doing online research. of all spend in 2018, far higher than television’s 30.8%
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Strategic Audience Targeting and Keyword Planning One of the key advantages of PPC campaigns in pharma marketing is their precision.
billion acquisition of One Medical, a primary care provider with 188 offices in 25 markets nationwide but are they making a strategic move or a mistake? ” At its core is an app and website that members can use to book appointments, track health records and renew prescriptions. 4our: Can HCPs trust patients?
Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. Do DTC marketers have a patient map to show the key touchpoints and where DTC marketing can provide the best ROI? Marketers need to know how and why patients went on therapy.
In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. By enforcing transparency, PBMs would need to release detailed information on prescription drug spending. 2024 stands at a critical juncture in the battle against soaring pharmacy costs. Transparency and reporting requirements.
Colorado’s Prescription Drug Affordability Review Board (PDAB) isn’t waiting for the Inflation Reduction Act (IRA) to lower prices on certain drugs starting in 2026. After the review board unanimously agreed that Stelara is "unaffordable," the drug could be subject to an upper payment limit in the state.
This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. Some patients love the brand of prescription drugs they take because simply “they work” Pharma companies do study brand names, but that’s only about the overall branding of the product.
In late 2022, Corcept’s marketing team found itself at a critical juncture in the dozen-year-long history of its established brand, Korlym®. In partnership with EVERSANA INTOUCH and Patients & Purpose, Corcept generated extensive insights via market research and advisory boards with new target providers and at-risk patients.
According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. Second, the pricing is not the product of a free market economy. In contrast, insulin prices in other developed countries, including neighboring Canada, have stayed the same.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content